1887

Journal of Medical Microbiology logo

Volume 57, Issue 3

Performance of chromID ESBL, a chromogenic medium for detection of producing extended-spectrum -lactamases Free

Abstract

The chromogenic agar medium chromID ESBL (bioMérieux) was compared with BLSE agar medium (AES) for selective isolation and presumptive identification of extended-spectrum -lactamase (ESBL)-producing from clinical samples. A total of 765 samples (468 rectal swabs, 255 urine samples and 42 pulmonary aspirations) obtained from 547 patients was processed. All bacterial strains isolated on either medium were further characterized using biochemical tests, and ESBL producers were confirmed by synergy testing. Genetic characterization of ESBL genes was determined by PCR. A total of 33 ESBL-producing strains [ (=16), (=8), spp. (=3), spp. (=5) and (=1)] was recovered. The sensitivity after 24 h incubation was 88 % for chromID ESBL and 85 % for BLSE agar. At 48 h, the sensitivity of chromID ESBL increased to 94 % and was higher than that obtained with BLSE agar. The positive predictive value at 24 h for chromID ESBL was 38.7 % [95 % confidence interval (95 % CI) 28.3 –50.2 %)], which was significantly higher than that for BLSE agar [15.4 %, 95 % CI 10.1 –21.5 %]. On both media, false-positive results were mostly due to and to overproducing chromosomal cephalosporinase ( spp.) or a chromosomal penicillinase (). This study showed that chromID ESBL, a ready-to-use chromogenic selective medium, is sensitive and specific for rapid, presumptive identification of ESBL-producing . Its chromogenic properties and its selectivity are particularly useful in specimens containing resident associated flora.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): 95 % CI, 95 % confidence interval , ESBL, extended-spectrum β-lactamase and PPV, positive predictive value
SGM
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.47625-0
2008-03-01
2024-04-18
Loading full text...

Full text loading...

/deliver/fulltext/jmm/57/3/310.html?itemId=/content/journal/jmm/10.1099/jmm.0.47625-0&mimeType=html&fmt=ahah

References

  1. Bonnet R., Sampaio J. L., Chanal C., Sirot D., De Champs C., Viallard J. L., Labia R., Sirot J. 2000; A novel class A extended-spectrum β -lactamase (BES-1) in Serratia marcescens isolated in Brazil. Antimicrob Agents Chemother 44:3061–3068 [CrossRef]
     [Google Scholar]
  2. Canton R., Coque T. M. 2006; The CTX-M β -lactamase pandemic. Curr Opin Microbiol 9:466–475 [CrossRef]
     [Google Scholar]
  3. CLSI 2005 Performance standards for antimicrobial susceptibility testing , 15th informational supplement, M100-S15 Wayne, PA: Clinical and Laboratory Standards Institute;
     [Google Scholar]
  4. Diederen B. M., van Leest M. L., van Duijn I., Willemse P., van Keulen P. H., Kluytmans J. A. 2006; Performance of MRSA ID, a new chromogenic medium for detection of methicillin-resistant Staphylococcus aureus . J Clin Microbiol 44:586–588 [CrossRef]
     [Google Scholar]
  5. Girlich D., Poirel L., Schluter A., Nordmann P. 2005; TLA-2, a novel Ambler class A expanded-spectrum β -lactamase. Antimicrob Agents Chemother 49:4767–4770 [CrossRef]
     [Google Scholar]
  6. Glupczynski Y., Berhin C., Bauraing C., Bogaerts P. 2007; Evaluation of a new selective chromogenic agar medium for detection of extended-spectrum β -lactamase-producing Enterobacteriaceae . J Clin Microbiol 45:501–505 [CrossRef]
     [Google Scholar]
  7. Jarlier V., Nicolas M. H., Fournier G., Philippon A. 1988; Extended broad-spectrum β -lactamases conferring transferable resistance to newer β -lactam agents in Enterobacteriaceae : hospital prevalence and susceptibility patterns. Rev Infect Dis 10:867–878 [CrossRef]
     [Google Scholar]
  8. Ledeboer N. A., Das K., Eveland M., Roger-Dalbert C., Mailler S., Chatellier S., Dunne W. M. 2007; Evaluation of a novel chromogenic agar medium for isolation and differentiation of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis . J Clin Microbiol 45:1556–1560 [CrossRef]
     [Google Scholar]
  9. Lucet J. C., Decre D., Fichelle A., Joly-Guillou M. L., Pernet M., Deblangy C., Kosmann M. J., Regnier B. 1999; Control of a prolonged outbreak of extended-spectrum β -lactamase-producing Enterobacteriaceae in a university hospital. Clin Infect Dis 29:1411–1418 [CrossRef]
     [Google Scholar]
  10. Naas T., Aubert D., Lambert T., Nordmann P. 2006; Complex genetic structures with repeated elements, a sul -type class 1 integron, and the bla VEB extended-spectrum β -lactamase gene. Antimicrob Agents Chemother 50:1745–1752 [CrossRef]
     [Google Scholar]
  11. Naas T., Oxacelay C., Nordmann P. 2007; Identification of CTX-M-type extended-spectrum- β -lactamase genes using real-time PCR and pyrosequencing. Antimicrob Agents Chemother 51:223–230 [CrossRef]
     [Google Scholar]
  12. Paterson D. L. 2006; Resistance in Gram-negative bacteria: Enterobacteriaceae . Am J Med 119:S20–S28
     [Google Scholar]
  13. Pena C., Gudiol C., Tubau F., Saballs M., Pujol M., Dominguez M. A., Calatayud L., Ariza J., Gudiol F. 1997; Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum β -lactamase (ESBL-KP) in the intensive care unit. J Hosp Infect 35:9–16 [CrossRef]
     [Google Scholar]
  14. Pfaller M. A., Segreti J. 2006; Overview of the epidemiological profile and laboratory detection of extended-spectrum β -lactamases. Clin Infect Dis 42:S153–S163 [CrossRef]
     [Google Scholar]
  15. Philippon L. N., Naas T., Bouthors A. T., Barakett V., Nordmann P. 1997; OXA-18, a class D clavulanic acid-inhibited extended-spectrum β -lactamase from Pseudomonas aeruginosa . Antimicrob Agents Chemother 41:2188–2195
     [Google Scholar]
  16. Pitout J. D., Nordmann P., Laupland K. B., Poirel L. 2005; Emergence of Enterobacteriaceae producing extended-spectrum β -lactamases (ESBLs) in the community. J Antimicrob Chemother 56:52–59 [CrossRef]
     [Google Scholar]
  17. Poirel L., Brinas L., Verlinde A., Ide L., Nordmann P. 2005; BEL-1, a novel clavulanic acid-inhibited extended-spectrum β -lactamase, and the class 1 integron In120 in Pseudomonas aeruginosa . Antimicrob Agents Chemother 49:3743–3748 [CrossRef]
     [Google Scholar]
  18. Ramphal R., Ambrose P. G. 2006; Extended-spectrum β -lactamases and clinical outcomes: current data. Clin Infect Dis 42:S164–S172 [CrossRef]
     [Google Scholar]
  19. Silva J., Aguilar C., Ayala G., Estrada M. A., Garza-Ramos U., Lara-Lemus R., Ledezma L. 2000; TLA-1: a new plasmid-mediated extended-spectrum β -lactamase from Escherichia coli . Antimicrob Agents Chemother 44:997–1003 [CrossRef]
     [Google Scholar]
  20. Valverde A., Coque T. M., Sanchez-Moreno M. P., Rollan A., Baquero F., Canton R. 2004; Dramatic increase in prevalence of fecal carriage of extended-spectrum β -lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 42:4769–4775 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.47625-0
Loading
Performance of chromID ESBL, a chromogenic medium for detection of Enterobacteriaceae producing extended-spectrum β-lactamases
J. Med. Microbiol. 57, 310 (2008); https://doi.org/10.1099/jmm.0.47625-0
/content/journal/jmm/10.1099/jmm.0.47625-0
/content/journal/jmm/10.1099/jmm.0.47625-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error